cancers
Erratum
Erratum: Castellví, M. et al. Pharmacological
Modulation of SAMHD1 Activity by CDK4/6
Inhibitors Improves Anticancer Therapy. Cancers
2020, 12, 713
Marc Castellví 1,2,† , Eudald Felip 2,3,† , Ifeanyi Jude Ezeonwumelu 1,2 , Roger Badia 1,2 ,
Edurne Garcia-Vidal 1,2 , Maria Pujantell 1,2 , Lucía Gutiérrez-Chamorro 1,2 , Iris Teruel 2,3 ,
Anna Martínez-Cardús 2,3 , Bonaventura Clotet 1,2 , Eva Riveira-Muñoz 1,2 , Mireia Margelí 2,3 ,
José A. Esté 1,4 and Ester Ballana 1,2, *
 1    IrsiCaixa AIDS Research Institute, Badalona, 08916 Catalonia, Spain; mcnadal89@gmail.com (M.C.);
      iezeonwumelu@irsicaixa.es (I.J.E.); rbadia@irsicaixa.es (R.B.); egvidal@irsicaixa.es (E.G.-V.);
      mpujantell@irsicaixa.es (M.P.); lgutierrez@irsicaixa.es (L.G.-C.); bclotet@irsicaixa.es (B.C.);
      eriveira@irsicaixa.es (E.R.-M.); jaeste@cienciatraducida.com (J.A.E.)
 2    Health Research Institute Germans Trias i Pujol (IGTP), Hospital Germans Trias i Pujol,
      Universitat Autònoma de Barcelona, 08916 Badalona, Spain; efelip@irsicaixa.es (E.F.);
      iteruel@iconcologia.net (I.T.); amartinezc@igtp.cat (A.M.-C.); mmargeli@iconcologia.net (M.M.)
 3    Institut Català d’Oncologia, Badalona, 08916 Catalonia, Spain
 4    Cienciatraducida, 08391 Barcelona, Spain
 *    Correspondence: eballana@irsicaixa.es
 †    Theses authors contributed equally this work.
                                                                                                           



 Received: 5 June 2020; Accepted: 8 June 2020; Published: 29 June 2020                                     





     The authors wish you make the following corrections to this paper [1].
     One contributor’s name was missing in the original version of the authorship. The original version of
the authorship is:
     Marc Castellví 1,2,† , Eudald Felip 2,3,† , Ifeanyi Jude Ezeonwumelu 1,2 , Roger Badia 1,2 ,
Edurne Garcia-Vidal 1,2 , Maria Pujantell 1,2 , Lucía Gutiérrez-Chamorro 1,2 , Iris Teruel 2,3 ,
Anna Martínez-Cardús 2,3 , Bonaventura Clotet 1,2 , Eva Riveira-Muñoz 1,2 , Mireia Margelí 2,3
and Ester Ballana 1,2, *
     and should be replaced with:
     Marc Castellví 1,2,† , Eudald Felip 2,3,† , Ifeanyi Jude Ezeonwumelu 1,2 , Roger Badia 1,2 ,
Edurne Garcia-Vidal 1,2 , Maria Pujantell 1,2 , Lucía Gutiérrez-Chamorro 1,2 , Iris Teruel 2,3 ,
Anna Martínez-Cardús 2,3 , Bonaventura Clotet 1,2 , Eva Riveira-Muñoz 1,2 , Mireia Margelí 2,3 ,
José A. Esté 1,4, and Ester Ballana 1,2, *
     The updated “Author Contributions” should be

Author Contributions: Conceptualization, J.A.E., E.R.-M., M.M. and E.B.; Formal analysis, M.M., J.A.E. and E.B.;
Investigation, M.C., E.F., I.J.E., R.B., E.G.-V., M.P. and L.G.-C.; Methodology, I.T. and A.M.-C.; Supervision, B.C.
and J.A.E.; Writing—original draft, E.B. and J.A.E.; Writing—review & editing, E.R.-M. and E.B. All authors have
read and agreed to the published version of the manuscript.




Cancers 2020, 12, 1728; doi:10.3390/cancers12071728                                   www.mdpi.com/journal/cancers
Cancers 2020, 12, 1728                                                                                          2 of 2



Reference
1.    Castellví, M.; Felip, E.; Ezeonwumelu, I.J.; Badia, R.; Garcia-Vidal, E.; Pujantell, M.; Gutiérrez-Chamorro, L.;
      Teruel, I.; Martínez-Cardús, A.; Clotet, B.; et al. Pharmacological Modulation of SAMHD1 Activity by
      CDK4/6 Inhibitors Improves Anticancer Therapy. Cancers 2020, 12, 713. [CrossRef]

                         © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
                         article distributed under the terms and conditions of the Creative Commons Attribution
                         (CC BY) license (http://creativecommons.org/licenses/by/4.0/).